GOSSAMER BIO, INC. (GOSS) Pre-Tax Margin
- 2025-12-31: Pre-Tax Margin -342.97%.
- 2025-09-30: Pre-Tax Margin -362.73%.
- 2025-06-30: Pre-Tax Margin -333.13%.
- 2024-12-31: Pre-Tax Margin -377.85%.
Complete source-backed pre-tax margin history.
- Available history
- 2024-06-30 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
| 2025-12-31 | -342.97% |
|---|
| 2025-09-30 | -362.73% |
|---|
| 2025-06-30 | -333.13% |
|---|
| 2024-12-31 | -377.85% |
|---|
| 2024-09-30 | -336.87% |
|---|
| 2024-06-30 | 56.00% |
|---|
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
| 2025-12-31 | -351.67% |
|---|
| 2024-12-31 | -48.50% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|